Getting your brand noticed early in its lifespan is a crucial component to pharmaceutical product position strategy said, Corinne Le Goff, vice president, marketing, at Sanofi-Aventis.
A report delivered by industry trade group PhRMA has found a record 750 potential cancer treatments in the US research pipeline, according to a statement.
The Journal of the American Medical Association called into question published clinical data and authorship surrounding Merck’s Vioxx (rofecoxib) in a scathing editorial.
Contract sales firm PDI signed a four-year agreement with Novartis to deploy a field force promoting Elidel, a second-line eczema treatment for patients older than 2 years, according to Kim Golodetz, a spokesperson for PDI.
Health insurers are shifting expensive drugs into “tier 4” classification, resulting in a price spike for some patients, according to a New York Times report.
Appeals court favors pre-emption defense in antidepressants case